Approval · Notice of Compliance 29727 · 2022
AURIMIC: Notice of Compliance 29727
Issued December 20, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29727
- Date
- December 20, 2022
- Company
- Richter Pharma Ag
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Manufacturing changes
- Canadian reference product
- SUROLAN (Elanco Division Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AURIMIC | 02509725 | Marketed |
Medicinal ingredients
- MICONAZOLE NITRATE 23 MG per ML
- PREDNISOLONE ACETATE 5 MG per ML
- POLYMYXIN B SULFATE 0.5293 MG per ML